A Pilot Study of Mindfulness-based Intervention for the Depressive Symptoms of Early Psychosis
European Psychiatry
Format:
Journal Article
Publication Date:
2015/03//
Pages:
854
Sources ID:
67661
Collection:
Mindfulness-Based Interventions for Depression
Visibility:
Public (group default)
Abstract:
(Show)
Background: Depressive and anxiety symptoms are common in people suffering from early psychosis. Growing evidence shows that mindfulness-based intervention is an effective option in handling depression and anxiety disorders. Current article aims to provide documentation on the development and pilot study, before a RCT of larger scale, evaluating the acceptability and potential effects of a 7-week mindfulness-based intervention programme (MBI-p). Method: MBI-p was developed over nine months in 2014. A total of 14 people with early psychosis were recruited to three pilot trials of MBI-p. Eleven of them completed the programme and were interviewed. Eight of them were measured quantitatively at baseline and post-intervention on clinical symptoms, depression and anxiety levels, quality of life and mindfulness. Results: Mixed qualitative and quantitative results supported MBI-p as an acceptable and feasible intervention. Significant statistical improvements were found in depression levels, mental quality of life, general psychopathology and ability to observe emotions and act with awareness. Qualitative comments suggested that the intervention was safe, enjoyable and had a positive impact on mood symptoms. In summary, these results provide a promising pilot support for a potentially effective and cost-efficient treatment option for people with early psychosis. Key Practitioner Message: • Depressive and anxiety symptoms are common in people with early psychosis but long received little attention. • A low-intensity mindfulness-based intervention targeting depression and anxiety symptoms among people with early psychosis was developed and pilot tested. • It is feasible and acceptable to use mindfulness-based intervention as a complementary treatment for psychosis.